These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. ADAM9 promotes lung cancer progression through vascular remodeling by VEGFA, ANGPT2, and PLAT. Lin CY; Cho CF; Bai ST; Liu JP; Kuo TT; Wang LJ; Lin YS; Lin CC; Lai LC; Lu TP; Hsieh CY; Chu CN; Cheng DC; Sher YP Sci Rep; 2017 Nov; 7(1):15108. PubMed ID: 29118335 [TBL] [Abstract][Full Text] [Related]
4. RNAi-mediated A disintegrin and metalloproteinase 9 gene silencing inhibits the tumor growth of non-small lung cancer in vitro and in vivo. Chang L; Gong F; Cui Y Mol Med Rep; 2015 Jul; 12(1):1197-204. PubMed ID: 25778452 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis. Shintani Y; Higashiyama S; Ohta M; Hirabayashi H; Yamamoto S; Yoshimasu T; Matsuda H; Matsuura N Cancer Res; 2004 Jun; 64(12):4190-6. PubMed ID: 15205330 [TBL] [Abstract][Full Text] [Related]
6. Identification of theranostic factors for patients developing metastasis after surgery for early-stage lung adenocarcinoma. Cheng WC; Chang CY; Lo CC; Hsieh CY; Kuo TT; Tseng GC; Wong SC; Chiang SF; Huang KC; Lai LC; Lu TP; Chao KSC; Sher YP Theranostics; 2021; 11(8):3661-3675. PubMed ID: 33664854 [No Abstract] [Full Text] [Related]
7. microRNA-590 suppresses the tumorigenesis and invasiveness of non-small cell lung cancer cells by targeting ADAM9. Wang FF; Wang S; Xue WH; Cheng JL Mol Cell Biochem; 2016 Dec; 423(1-2):29-37. PubMed ID: 27770372 [TBL] [Abstract][Full Text] [Related]
8. ADAM9 up-regulates N-cadherin via miR-218 suppression in lung adenocarcinoma cells. Sher YP; Wang LJ; Chuang LL; Tsai MH; Kuo TT; Huang CC; Chuang EY; Lai LC PLoS One; 2014; 9(4):e94065. PubMed ID: 24705471 [TBL] [Abstract][Full Text] [Related]
9. ADAM9 promotes lung cancer metastases to brain by a plasminogen activator-based pathway. Lin CY; Chen HJ; Huang CC; Lai LC; Lu TP; Tseng GC; Kuo TT; Kuok QY; Hsu JL; Sung SY; Hung MC; Sher YP Cancer Res; 2014 Sep; 74(18):5229-43. PubMed ID: 25060522 [TBL] [Abstract][Full Text] [Related]
10. α1-antitrypsin promotes lung adenocarcinoma metastasis through upregulating fibronectin expression. Li Y; Miao L; Yu M; Shi M; Wang Y; Yang J; Xiao Y; Cai H Int J Oncol; 2017 Jun; 50(6):1955-1964. PubMed ID: 28440399 [TBL] [Abstract][Full Text] [Related]
11. Oxidative stress induces ADAM9 protein expression in human prostate cancer cells. Sung SY; Kubo H; Shigemura K; Arnold RS; Logani S; Wang R; Konaka H; Nakagawa M; Mousses S; Amin M; Anderson C; Johnstone P; Petros JA; Marshall FF; Zhau HE; Chung LW Cancer Res; 2006 Oct; 66(19):9519-26. PubMed ID: 17018608 [TBL] [Abstract][Full Text] [Related]
12. ADAM9 enhances CDCP1 by inhibiting miR-1 through EGFR signaling activation in lung cancer metastasis. Chiu KL; Lin YS; Kuo TT; Lo CC; Huang YK; Chang HF; Chuang EY; Lin CC; Cheng WC; Liu YN; Lai LC; Sher YP Oncotarget; 2017 Jul; 8(29):47365-47378. PubMed ID: 28537886 [TBL] [Abstract][Full Text] [Related]
13. The effect of disintegrin-metalloproteinase ADAM9 in gastric cancer progression. Kim JM; Jeung HC; Rha SY; Yu EJ; Kim TS; Shin YK; Zhang X; Park KH; Park SW; Chung HC; Powis G Mol Cancer Ther; 2014 Dec; 13(12):3074-85. PubMed ID: 25344581 [TBL] [Abstract][Full Text] [Related]
14. ADAM9 enhances CDCP1 protein expression by suppressing miR-218 for lung tumor metastasis. Chiu KL; Kuo TT; Kuok QY; Lin YS; Hua CH; Lin CY; Su PY; Lai LC; Sher YP Sci Rep; 2015 Nov; 5():16426. PubMed ID: 26553452 [TBL] [Abstract][Full Text] [Related]
15. ADAM9 functions as a promoter of gastric cancer growth which is negatively and post-transcriptionally regulated by miR-126. Wang J; Zhou Y; Fei X; Chen X; Yan J; Liu B; Zhu Z Oncol Rep; 2017 Apr; 37(4):2033-2040. PubMed ID: 28260063 [TBL] [Abstract][Full Text] [Related]
16. Tumor invasion induced by oxidative stress is dependent on membrane ADAM 9 protein and its secreted form. Mongaret C; Alexandre J; Thomas-Schoemann A; Bermudez E; Chéreau C; Nicco C; Goldwasser F; Weill B; Batteux F; Lemare F Int J Cancer; 2011 Aug; 129(4):791-8. PubMed ID: 21064090 [TBL] [Abstract][Full Text] [Related]
17. The pleiotropic roles of ADAM9 in the biology of solid tumors. Oria VO; Lopatta P; Schilling O Cell Mol Life Sci; 2018 Jul; 75(13):2291-2301. PubMed ID: 29550974 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-126 inhibits invasion in bladder cancer via regulation of ADAM9. Jia AY; Castillo-Martin M; Bonal DM; Sánchez-Carbayo M; Silva JM; Cordon-Cardo C Br J Cancer; 2014 Jun; 110(12):2945-54. PubMed ID: 24823697 [TBL] [Abstract][Full Text] [Related]
19. Loss of tumor suppressor miR-126 contributes to the development of hepatitis B virus-related hepatocellular carcinoma metastasis through the upregulation of ADAM9. Xiang LY; Ou HH; Liu XC; Chen ZJ; Li XH; Huang Y; Yang DH Tumour Biol; 2017 Jun; 39(6):1010428317709128. PubMed ID: 28639884 [TBL] [Abstract][Full Text] [Related]
20. Prognostic value of Mortalin correlates with roles in epithelial-mesenchymal transition and angiogenesis in lung adenocarcinoma. Meng Z; Zhang R; Wu X; Zhang M; Zhang S; Jin T Carcinogenesis; 2022 Feb; 43(1):40-51. PubMed ID: 34490878 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]